Uremic Pericarditis: A Critical Case Study in Renal Failure

It often starts with a dull, persistent ache in the center of the chest. For patients with advanced chronic kidney disease, this discomfort isn't just a minor inconvenience. It is a red flag. When the kidneys fail to filter waste products from the blood, toxins accumulate. One of the most serious complications of this buildup is inflammation of the pericardium, the sac surrounding the heart. This condition, known as uremic pericarditis, represents a medical emergency that requires immediate attention.

In clinical practice, we often see this diagnosis emerge when other common causes of chest pain, like acute coronary syndrome, have been ruled out. It serves as a stark reminder of how systemic disease can impact every organ. Let’s look at a detailed case report that illustrates the classic presentation, the diagnostic challenges, and the critical steps taken to manage this life-threatening condition.

The Patient Presentation: More Than Just Fatigue

Consider the case of a 58-year-old male admitted to the internal medicine ward. He had a known history of stage 4 chronic kidney disease secondary to diabetic nephropathy. He had been non-compliant with his dialysis schedule for the past two weeks due to work commitments and a lack of transportation. Upon admission, he was lethargic and appeared generally unwell.

The primary complaint was a sharp, pleuritic chest pain that worsened when he lay flat and improved slightly when he sat up and leaned forward. This positional nature of the pain is a hallmark sign. Accompanying symptoms included shortness of breath, particularly when lying down, and a low-grade fever. His blood pressure was elevated at 150/95 mmHg, but his heart rate was surprisingly high, clocking in at 110 beats per minute.

Physical examination revealed several critical findings. The most significant was a pericardial friction rub heard best at the left sternal border during expiration. This scratching, grating sound is pathognomonic for pericardial inflammation. There were no signs of jugular venous distension, which helped rule out cardiac tamponade at that initial stage. However, the patient’s lungs were clear, suggesting that the dyspnea was driven more by the pericardial issue than by fluid overload alone.

Diagnostic Workup: Connecting the Dots

Differentiating uremic pericarditis from other causes of chest pain is crucial. In this case, the first step was obtaining a 12-lead ECG. The results showed diffuse ST-segment elevation with PR-segment depression. Unlike a heart attack, where changes are localized to specific territories, these changes were widespread. This global inflammation pattern pointed strongly toward pericarditis rather than an acute myocardial infarction.

Blood work provided the remaining evidence. The patient’s serum creatinine was critically high at 8.5 mg/dL, and his blood urea nitrogen (BUN) levels were over 100 mg/dL. The anion gap metabolic acidosis was also present, reflecting the severe accumulation of uremic toxins. While C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were elevated, indicating systemic inflammation, they are non-specific markers. The true diagnostic key was the combination of the clinical picture, the ECG findings, and the severe biochemical evidence of uremia.

• Ecardiography: A bedside echocardiogram revealed a moderate pericardial effusion. Crucially, there was no evidence of right atrial collapse or significant respiratory variation in mitral inflow, confirming that tamponade physiology was not yet present.
• Rule Outs: Troponin levels were only mildly elevated, likely due to renal clearance issues rather than acute necrosis. Vascular risk factors were managed, but the primary driver remained renal.

Management Strategy: Dialysis as the Cure

Treating uremic pericarditis differs significantly from viral or idiopathic pericarditis. In typical cases, we rely heavily on NSAIDs and colchicine. However, in uremic cases, the primary treatment is aggressive dialysis. The inflammation is driven by the toxin load in the blood. Therefore, removing those toxins is the only way to stop the inflammatory process.

In this patient’s case, we initiated urgent hemodialysis. We increased the frequency of sessions, moving from his usual intermittent schedule to more intensive daily treatments. The goal was to rapidly lower the BUN and creatinine levels. We monitored his hemodynamics closely during these sessions to ensure he remained stable.

It is important to note that NSAIDs are generally used with caution in these patients. Since many have compromised kidney function or are already on antiplatelet agents, the risk of gastrointestinal bleeding or further renal injury is high. In severe cases where pain is unmanageable, low-dose aspirin may be considered, but it is not the first-line therapy. The cornerstone remains renal replacement therapy.

After seven days of intensive dialysis, the patient’s BUN levels dropped below 50 mg/dL. The chest pain resolved completely. The friction rub disappeared on physical exam. A follow-up echocardiogram showed a significant reduction in the pericardial effusion size. He was discharged with a strict education plan regarding the importance of adherence to his dialysis schedule moving forward.

Why Adherence Matters

This case highlights a preventable complication. Uremic pericarditis is often a marker of severe, untreated, or undertreated kidney failure. It is associated with high mortality if left unaddressed. The friction rub is a transient sign; its presence suggests active inflammation, while its absence does not rule out effusion.

For healthcare providers, recognizing the subtle signs early is vital. For patients, understanding that skipping dialysis doesn't just lead to fatigue but can literally inflame the sac around the heart is a powerful motivator for compliance. The connection between renal health and cardiac stability is undeniable.